- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Hormonal Contraception is a type of birth control that uses hormones to prevent pregnancy.
According to our latest study, the global Hormonal Contraception market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Hormonal Contraception market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hormonal Contraception market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hormonal Contraception market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hormonal Contraception market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hormonal Contraception market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hormonal Contraception
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hormonal Contraception market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc. and Teva Pharmaceutical Industries Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hormonal Contraception market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
by Hormone
Androgens
Estrogens
Progestrogens
Antiandrogens
Gonadotropins
by Method
Combined Oral
Oral Pill
Implanted
Injected
Intrauterine
Transdermal Patch
Market segment by Application
Hospital
Clinics
Gynaecology Centers
Others
Major players covered
Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Agile Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Amgen
Cipla Ltd.
Glenmark Pharmaceuticals Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis AG
Mylan N.V.
Johnson & Johnson
Ansell LTD
Mayer Laboratories, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hormonal Contraception product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hormonal Contraception, with price, sales, revenue and global market share of Hormonal Contraception from 2018 to 2023.
Chapter 3, the Hormonal Contraception competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hormonal Contraception breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hormonal Contraception market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hormonal Contraception.
Chapter 14 and 15, to describe Hormonal Contraception sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Hormonal Contraception
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hormonal Contraception Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Androgens
1.3.3 Estrogens
1.3.4 Progestrogens
1.3.5 Antiandrogens
1.3.6 Gonadotropins
1.4 Market Analysis by Application
1.4.1 Overview: Global Hormonal Contraception Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Gynaecology Centers
1.4.5 Others
1.5 Global Hormonal Contraception Market Size & Forecast
1.5.1 Global Hormonal Contraception Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hormonal Contraception Sales Quantity (2018-2029)
1.5.3 Global Hormonal Contraception Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Hormonal Contraception Product and Services
2.1.4 Bayer AG Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer AG Recent Developments/Updates
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business
2.2.3 Merck & Co., Inc. Hormonal Contraception Product and Services
2.2.4 Merck & Co., Inc. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co., Inc. Recent Developments/Updates
2.3 Pfizer, Inc.
2.3.1 Pfizer, Inc. Details
2.3.2 Pfizer, Inc. Major Business
2.3.3 Pfizer, Inc. Hormonal Contraception Product and Services
2.3.4 Pfizer, Inc. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer, Inc. Recent Developments/Updates
2.4 Agile Therapeutics, Inc.
2.4.1 Agile Therapeutics, Inc. Details
2.4.2 Agile Therapeutics, Inc. Major Business
2.4.3 Agile Therapeutics, Inc. Hormonal Contraception Product and Services
2.4.4 Agile Therapeutics, Inc. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Agile Therapeutics, Inc. Recent Developments/Updates
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product and Services
2.5.4 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Hormonal Contraception Product and Services
2.6.4 Amgen Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amgen Recent Developments/Updates
2.7 Cipla Ltd.
2.7.1 Cipla Ltd. Details
2.7.2 Cipla Ltd. Major Business
2.7.3 Cipla Ltd. Hormonal Contraception Product and Services
2.7.4 Cipla Ltd. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cipla Ltd. Recent Developments/Updates
2.8 Glenmark Pharmaceuticals Inc.
2.8.1 Glenmark Pharmaceuticals Inc. Details
2.8.2 Glenmark Pharmaceuticals Inc. Major Business
2.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Product and Services
2.8.4 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
2.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
2.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Details
2.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Major Business
2.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product and Services
2.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Hormonal Contraception Product and Services
2.10.4 Novartis AG Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novartis AG Recent Developments/Updates
2.11 Mylan N.V.
2.11.1 Mylan N.V. Details
2.11.2 Mylan N.V. Major Business
2.11.3 Mylan N.V. Hormonal Contraception Product and Services
2.11.4 Mylan N.V. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mylan N.V. Recent Developments/Updates
2.12 Johnson & Johnson
2.12.1 Johnson & Johnson Details
2.12.2 Johnson & Johnson Major Business
2.12.3 Johnson & Johnson Hormonal Contraception Product and Services
2.12.4 Johnson & Johnson Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Johnson & Johnson Recent Developments/Updates
2.13 Ansell LTD
2.13.1 Ansell LTD Details
2.13.2 Ansell LTD Major Business
2.13.3 Ansell LTD Hormonal Contraception Product and Services
2.13.4 Ansell LTD Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ansell LTD Recent Developments/Updates
2.14 Mayer Laboratories, Inc.
2.14.1 Mayer Laboratories, Inc. Details
2.14.2 Mayer Laboratories, Inc. Major Business
2.14.3 Mayer Laboratories, Inc. Hormonal Contraception Product and Services
2.14.4 Mayer Laboratories, Inc. Hormonal Contraception Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Mayer Laboratories, Inc. Recent Developments/Updates
3 Competitive Environment: Hormonal Contraception by Manufacturer
3.1 Global Hormonal Contraception Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hormonal Contraception Revenue by Manufacturer (2018-2023)
3.3 Global Hormonal Contraception Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hormonal Contraception by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hormonal Contraception Manufacturer Market Share in 2022
3.4.2 Top 6 Hormonal Contraception Manufacturer Market Share in 2022
3.5 Hormonal Contraception Market: Overall Company Footprint Analysis
3.5.1 Hormonal Contraception Market: Region Footprint
3.5.2 Hormonal Contraception Market: Company Product Type Footprint
3.5.3 Hormonal Contraception Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hormonal Contraception Market Size by Region
4.1.1 Global Hormonal Contraception Sales Quantity by Region (2018-2029)
4.1.2 Global Hormonal Contraception Consumption Value by Region (2018-2029)
4.1.3 Global Hormonal Contraception Average Price by Region (2018-2029)
4.2 North America Hormonal Contraception Consumption Value (2018-2029)
4.3 Europe Hormonal Contraception Consumption Value (2018-2029)
4.4 Asia-Pacific Hormonal Contraception Consumption Value (2018-2029)
4.5 South America Hormonal Contraception Consumption Value (2018-2029)
4.6 Middle East and Africa Hormonal Contraception Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hormonal Contraception Sales Quantity by Type (2018-2029)
5.2 Global Hormonal Contraception Consumption Value by Type (2018-2029)
5.3 Global Hormonal Contraception Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hormonal Contraception Sales Quantity by Application (2018-2029)
6.2 Global Hormonal Contraception Consumption Value by Application (2018-2029)
6.3 Global Hormonal Contraception Average Price by Application (2018-2029)
7 North America
7.1 North America Hormonal Contraception Sales Quantity by Type (2018-2029)
7.2 North America Hormonal Contraception Sales Quantity by Application (2018-2029)
7.3 North America Hormonal Contraception Market Size by Country
7.3.1 North America Hormonal Contraception Sales Quantity by Country (2018-2029)
7.3.2 North America Hormonal Contraception Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hormonal Contraception Sales Quantity by Type (2018-2029)
8.2 Europe Hormonal Contraception Sales Quantity by Application (2018-2029)
8.3 Europe Hormonal Contraception Market Size by Country
8.3.1 Europe Hormonal Contraception Sales Quantity by Country (2018-2029)
8.3.2 Europe Hormonal Contraception Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hormonal Contraception Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hormonal Contraception Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hormonal Contraception Market Size by Region
9.3.1 Asia-Pacific Hormonal Contraception Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hormonal Contraception Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hormonal Contraception Sales Quantity by Type (2018-2029)
10.2 South America Hormonal Contraception Sales Quantity by Application (2018-2029)
10.3 South America Hormonal Contraception Market Size by Country
10.3.1 South America Hormonal Contraception Sales Quantity by Country (2018-2029)
10.3.2 South America Hormonal Contraception Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hormonal Contraception Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hormonal Contraception Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hormonal Contraception Market Size by Country
11.3.1 Middle East & Africa Hormonal Contraception Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hormonal Contraception Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hormonal Contraception Market Drivers
12.2 Hormonal Contraception Market Restraints
12.3 Hormonal Contraception Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hormonal Contraception and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hormonal Contraception
13.3 Hormonal Contraception Production Process
13.4 Hormonal Contraception Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hormonal Contraception Typical Distributors
14.3 Hormonal Contraception Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Hormonal Contraception Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hormonal Contraception Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Hormonal Contraception Product and Services
Table 6. Bayer AG Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer AG Recent Developments/Updates
Table 8. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co., Inc. Major Business
Table 10. Merck & Co., Inc. Hormonal Contraception Product and Services
Table 11. Merck & Co., Inc. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck & Co., Inc. Recent Developments/Updates
Table 13. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer, Inc. Major Business
Table 15. Pfizer, Inc. Hormonal Contraception Product and Services
Table 16. Pfizer, Inc. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer, Inc. Recent Developments/Updates
Table 18. Agile Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Agile Therapeutics, Inc. Major Business
Table 20. Agile Therapeutics, Inc. Hormonal Contraception Product and Services
Table 21. Agile Therapeutics, Inc. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Agile Therapeutics, Inc. Recent Developments/Updates
Table 23. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. Major Business
Table 25. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 28. Amgen Basic Information, Manufacturing Base and Competitors
Table 29. Amgen Major Business
Table 30. Amgen Hormonal Contraception Product and Services
Table 31. Amgen Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amgen Recent Developments/Updates
Table 33. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Cipla Ltd. Major Business
Table 35. Cipla Ltd. Hormonal Contraception Product and Services
Table 36. Cipla Ltd. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cipla Ltd. Recent Developments/Updates
Table 38. Glenmark Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Glenmark Pharmaceuticals Inc. Major Business
Table 40. Glenmark Pharmaceuticals Inc. Hormonal Contraception Product and Services
Table 41. Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Glenmark Pharmaceuticals Inc. Recent Developments/Updates
Table 43. Lupin Limited(Lupin Pharmaceuticals, Inc.) Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Limited(Lupin Pharmaceuticals, Inc.) Major Business
Table 45. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product and Services
Table 46. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
Table 48. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 49. Novartis AG Major Business
Table 50. Novartis AG Hormonal Contraception Product and Services
Table 51. Novartis AG Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis AG Recent Developments/Updates
Table 53. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 54. Mylan N.V. Major Business
Table 55. Mylan N.V. Hormonal Contraception Product and Services
Table 56. Mylan N.V. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Mylan N.V. Recent Developments/Updates
Table 58. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 59. Johnson & Johnson Major Business
Table 60. Johnson & Johnson Hormonal Contraception Product and Services
Table 61. Johnson & Johnson Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Ansell LTD Basic Information, Manufacturing Base and Competitors
Table 64. Ansell LTD Major Business
Table 65. Ansell LTD Hormonal Contraception Product and Services
Table 66. Ansell LTD Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Ansell LTD Recent Developments/Updates
Table 68. Mayer Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Mayer Laboratories, Inc. Major Business
Table 70. Mayer Laboratories, Inc. Hormonal Contraception Product and Services
Table 71. Mayer Laboratories, Inc. Hormonal Contraception Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Mayer Laboratories, Inc. Recent Developments/Updates
Table 73. Global Hormonal Contraception Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Hormonal Contraception Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Hormonal Contraception Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Hormonal Contraception, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Hormonal Contraception Production Site of Key Manufacturer
Table 78. Hormonal Contraception Market: Company Product Type Footprint
Table 79. Hormonal Contraception Market: Company Product Application Footprint
Table 80. Hormonal Contraception New Market Entrants and Barriers to Market Entry
Table 81. Hormonal Contraception Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Hormonal Contraception Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Hormonal Contraception Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Hormonal Contraception Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Hormonal Contraception Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Hormonal Contraception Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Hormonal Contraception Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Hormonal Contraception Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Hormonal Contraception Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Hormonal Contraception Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Hormonal Contraception Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Hormonal Contraception Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Hormonal Contraception Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Hormonal Contraception Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Hormonal Contraception Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Hormonal Contraception Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Hormonal Contraception Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Hormonal Contraception Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Hormonal Contraception Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Hormonal Contraception Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Hormonal Contraception Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Hormonal Contraception Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Hormonal Contraception Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Hormonal Contraception Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Hormonal Contraception Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Hormonal Contraception Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Hormonal Contraception Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Hormonal Contraception Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Hormonal Contraception Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Hormonal Contraception Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Hormonal Contraception Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Hormonal Contraception Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Hormonal Contraception Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Hormonal Contraception Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Hormonal Contraception Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Hormonal Contraception Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Hormonal Contraception Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Hormonal Contraception Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Hormonal Contraception Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Hormonal Contraception Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Hormonal Contraception Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Hormonal Contraception Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Hormonal Contraception Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Hormonal Contraception Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Hormonal Contraception Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Hormonal Contraception Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Hormonal Contraception Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Hormonal Contraception Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Hormonal Contraception Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Hormonal Contraception Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Hormonal Contraception Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Hormonal Contraception Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Hormonal Contraception Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Hormonal Contraception Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Hormonal Contraception Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Hormonal Contraception Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Hormonal Contraception Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Hormonal Contraception Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Hormonal Contraception Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Hormonal Contraception Raw Material
Table 141. Key Manufacturers of Hormonal Contraception Raw Materials
Table 142. Hormonal Contraception Typical Distributors
Table 143. Hormonal Contraception Typical Customers
List of Figures
Figure 1. Hormonal Contraception Picture
Figure 2. Global Hormonal Contraception Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hormonal Contraception Consumption Value Market Share by Type in 2022
Figure 4. Androgens Examples
Figure 5. Estrogens Examples
Figure 6. Progestrogens Examples
Figure 7. Antiandrogens Examples
Figure 8. Gonadotropins Examples
Figure 9. Global Hormonal Contraception Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Hormonal Contraception Consumption Value Market Share by Application in 2022
Figure 11. Hospital Examples
Figure 12. Clinics Examples
Figure 13. Gynaecology Centers Examples
Figure 14. Others Examples
Figure 15. Global Hormonal Contraception Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Hormonal Contraception Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Hormonal Contraception Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Hormonal Contraception Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Hormonal Contraception Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Hormonal Contraception Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Hormonal Contraception by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Hormonal Contraception Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Hormonal Contraception Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Hormonal Contraception Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Hormonal Contraception Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Hormonal Contraception Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Hormonal Contraception Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Hormonal Contraception Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Hormonal Contraception Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Hormonal Contraception Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Hormonal Contraception Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Hormonal Contraception Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Hormonal Contraception Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Hormonal Contraception Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Hormonal Contraception Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Hormonal Contraception Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Hormonal Contraception Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Hormonal Contraception Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Hormonal Contraception Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Hormonal Contraception Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Hormonal Contraception Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Hormonal Contraception Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Hormonal Contraception Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Hormonal Contraception Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Hormonal Contraception Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Hormonal Contraception Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Hormonal Contraception Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Hormonal Contraception Consumption Value Market Share by Region (2018-2029)
Figure 57. China Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Hormonal Contraception Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Hormonal Contraception Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Hormonal Contraception Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Hormonal Contraception Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Hormonal Contraception Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Hormonal Contraception Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Hormonal Contraception Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Hormonal Contraception Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Hormonal Contraception Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Hormonal Contraception Market Drivers
Figure 78. Hormonal Contraception Market Restraints
Figure 79. Hormonal Contraception Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Hormonal Contraception in 2022
Figure 82. Manufacturing Process Analysis of Hormonal Contraception
Figure 83. Hormonal Contraception Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
